RT Journal Article
SR Electronic
T1 Heterogeneous aging across multiple organ systems and prediction of chronic disease and mortality
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.09.03.22279337
DO 10.1101/2022.09.03.22279337
A1 Tian, Ye Ella
A1 Cropley, Vanessa
A1 Maier, Andrea B.
A1 Lautenschlager, Nicola T.
A1 Breakspear, Michael
A1 Zalesky, Andrew
YR 2023
UL http://medrxiv.org/content/early/2023/03/06/2022.09.03.22279337.abstract
AB Biological aging of human organ systems reflects the interplay of age, chronic disease, lifestyle and genetic risk. Using longitudinal brain imaging and physiological phenotypes from the UK Biobank, we establish normative models of biological age for 3 brain and 7 body systems. We find that an organ’s biological age selectively influences the aging of other organ systems, revealing a multiorgan aging network. We report organ age profiles for 16 chronic diseases, where advanced biological aging extends from the organ of primary disease to multiple systems. Advanced body age associates with several lifestyle and environmental factors, leucocyte telomere lengths and mortality risk, and predicts survival time (AUC=0.77) and premature death (AUC=0.86). Our work reveals the multisystem nature of human aging in health and chronic disease. It may enable early identification of individuals at increased risk of aging-related morbidity and inform new strategies to potentially limit organ-specific aging in such individuals.Competing Interest StatementThe authors have declared no competing interest.Funding StatementY.E.T was supported by the Mary Lugton Postdoctoral Fellowship. A.Z. was supported by the National Health and Medical Research Council (NHMRC) grant (APP1142801 and APP118153). V.C. was supported by the NHMRC grant (APP1177370). M.B. was supported by the NHMRC grant (IG2008612, APP1095227 and APP1092623).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The UK Biobank has approval from the North West Multi-centre Research Ethics Committee (MREC) to obtain and disseminate data and samples from the participants (http://www.ukbiobank.ac.uk/ethics/). Written informed consent was obtained from all participants.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesResearchers can register to access all data used in this study via the UK Biobank Access Management System (https://bbams.ndph.ox.ac.uk/ams/).